TTC28 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.085780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.993600E-01
Normal-vs-Stage2
1.310850E-01
Normal-vs-Stage3
4.713700E-02
Normal-vs-Stage4
4.988800E-01
Stage1-vs-Stage2
5.271600E-01
Stage1-vs-Stage3
2.157200E-01
Stage1-vs-Stage4
8.376400E-01
Stage2-vs-Stage3
5.111600E-01
Stage2-vs-Stage4
4.538200E-01
Stage3-vs-Stage4
2.371800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.932200E-02
Normal-vs-AfricanAmerican
5.506400E-01
Normal-vs-Asian
1.467230E-01
Caucasian-vs-AfricanAmerican
2.651800E-01
Caucasian-vs-Asian
6.571800E-01
AfricanAmerican-vs-Asian
3.383400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.329600E-02
Normal-vs-Female
1.445620E-01
Male-vs-Female
2.746800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.866600E-01
Normal-vs-Age(41-60Yrs)
2.297800E-01
Normal-vs-Age(61-80Yrs)
8.028100E-02
Normal-vs-Age(81-100Yrs)
5.404200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.095200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.956600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.625000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.272400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.954040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.590800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.416000E-02
Normal-vs-Daily Drinker
4.603700E-03
Normal-vs-Weekly Drinker
3.084600E-01
Normal-vs-Occasional Drinker
4.158000E-02
Normal-vs-Social Drinker
4.906800E-01
Non Drinker-vs-Daily Drinker
2.501400E-01
Non Drinker-vs-Weekly Drinker
2.574200E-01
Non Drinker-vs-Occasional Drinker
6.036200E-01
Non Drinker-vs-Social Drinker
2.225400E-01
Daily Drinker-vs-Weekly Drinker
2.753700E-02
Daily Drinker-vs-Occasional Drinker
5.871200E-01
Daily Drinker-vs-Social Drinker
7.707700E-02
Weekly Drinker-vs-Occasional Drinker
1.362010E-01
Weekly Drinker-vs-Social Drinker
8.710200E-01
Occasional Drinker-vs-Social Drinker
1.480210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.883000E-01
Normal-vs-Grade 2
9.641000E-01
Normal-vs-Grade 3
9.070000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.948000E-01
Grade 1-vs-Grade 3
8.055400E-01
Grade 1-vs-Grade 4
8.883000E-01
Grade 2-vs-Grade 3
3.507000E-01
Grade 2-vs-Grade 4
9.641000E-01
Grade 3-vs-Grade 4
9.070000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.109600E-01
Normal-vs-NonDiabetic
7.126500E-02
Diabetic-vs-NonDiabetic
5.850800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.242400E-02
Normal-vs-NoPancreatitis
9.306000E-02
Pancreatitis-vs-NoPancreatitis
6.808800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.196100E-02
Normal-vs-N1
1.412040E-01
N0-vs-N1
2.877800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.667930E-02
Normal-vs-TP53-NonMutant
3.021400E-01
TP53-Mutant-vs-TP53-NonMutant
2.715600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
